BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A. miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol. 2008;48:648-656. [PMID: 18291553 DOI: 10.1016/j.jhep.2008.01.019] [Cited by in Crossref: 256] [Cited by in F6Publishing: 253] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Guo L, Yang X, Duan T. Altered microRNA expression profile in maternal and fetal liver of HBV transgenic mouse model. The Journal of Maternal-Fetal & Neonatal Medicine 2012;25:2071-7. [DOI: 10.3109/14767058.2012.678431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Sarma NJ, Tiriveedhi V, Subramanian V, Shenoy S, Crippin JS, Chapman WC, Mohanakumar T. Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One. 2012;7:e50826. [PMID: 23226395 DOI: 10.1371/journal.pone.0050826] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
3 Nakao K, Miyaaki H, Ichikawa T. Antitumor function of microRNA-122 against hepatocellular carcinoma. J Gastroenterol. 2014;49:589-593. [PMID: 24531873 DOI: 10.1007/s00535-014-0932-4] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 9.9] [Reference Citation Analysis]
4 Liu G, Ma X, Wang Z, Wakae K, Yuan Y, He Z, Yoshiyama H, Iizasa H, Zhang H, Matsuda M, Sugiyama R, Yuan Z, Muramatsu M, Li L. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing. J Biol Chem 2019;294:14043-54. [PMID: 31366735 DOI: 10.1074/jbc.RA119.007970] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
5 Gatti DM, Lu L, Williams RW, Sun W, Wright FA, Threadgill DW, Rusyn I. MicroRNA expression in the livers of inbred mice. Mutat Res 2011;714:126-33. [PMID: 21616085 DOI: 10.1016/j.mrfmmm.2011.05.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
6 Ulitsky I, Laurent LC, Shamir R. Towards computational prediction of microRNA function and activity. Nucleic Acids Res 2010;38:e160. [PMID: 20576699 DOI: 10.1093/nar/gkq570] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
7 Hu J, Xu Y, Hao J, Wang S, Li C, Meng S. MiR-122 in hepatic function and liver diseases. Protein Cell 2012;3:364-71. [PMID: 22610888 DOI: 10.1007/s13238-012-2036-3] [Cited by in Crossref: 110] [Cited by in F6Publishing: 111] [Article Influence: 11.0] [Reference Citation Analysis]
8 Ohta K, Hoshino H, Wang J, Ono S, Iida Y, Hata K, Huang SK, Colquhoun S, Hoon DS. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A. Oncotarget. 2015;6:3211-3224. [PMID: 25633810 DOI: 10.18632/oncotarget.3085] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 16.8] [Reference Citation Analysis]
9 Boesch-Saadatmandi C, Wagner AE, Wolffram S, Rimbach G. Effect of quercetin on inflammatory gene expression in mice liver in vivo - role of redox factor 1, miRNA-122 and miRNA-125b. Pharmacol Res. 2012;65:523-530. [PMID: 22402395 DOI: 10.1016/j.phrs.2012.02.007] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 8.3] [Reference Citation Analysis]
10 Zhao X, Chen Z, Zhou Z, Li Y, Wang Y, Zhou Z, Lu H, Sun C, Chu X. High-throughput sequencing of small RNAs and analysis of differentially expressed microRNAs associated with high-fat diet-induced hepatic insulin resistance in mice. Genes Nutr 2019;14:6. [PMID: 30820263 DOI: 10.1186/s12263-019-0630-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
11 Sun RP, Xi QY, Sun JJ, Cheng X, Zhu YL, Ye DZ, Chen T, Wei LM, Ye RS, Jiang QY. In low protein diets, microRNA-19b regulates urea synthesis by targeting SIRT5. Sci Rep. 2016;6:33291. [PMID: 27686746 DOI: 10.1038/srep33291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
12 Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, Chen L, Chen Y, Duan Z, Meng S. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 2010;398:771-7. [PMID: 20633528 DOI: 10.1016/j.bbrc.2010.07.021] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 9.2] [Reference Citation Analysis]
13 Rotllan N, Fernández-Hernando C. MicroRNA Regulation of Cholesterol Metabolism. Cholesterol 2012;2012:847849. [PMID: 22919472 DOI: 10.1155/2012/847849] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
14 Meiliana A, Wijaya A. MicroRNAs in Lipid Metabolism and Atherosclerosis. Indones Biomed J 2014;6:3. [DOI: 10.18585/inabj.v6i1.39] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Li X, Yang Y, Wang L, Qiao S, Lu X, Wu Y, Xu B, Li H, Gu D. Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome. PLoS One. 2015;10:e0125430. [PMID: 25933289 DOI: 10.1371/journal.pone.0125430] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
16 Ameling S, Kacprowski T, Chilukoti RK, Malsch C, Liebscher V, Suhre K, Pietzner M, Friedrich N, Homuth G, Hammer E, Völker U. Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study. BMC Med Genomics 2015;8:61. [PMID: 26462558 DOI: 10.1186/s12920-015-0136-7] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 12.9] [Reference Citation Analysis]
17 Boštjančič E, Večerić-Haler Ž, Kojc N. The Role of Immune-Related miRNAs in the Pathology of Kidney Transplantation. Biomolecules 2021;11:1198. [PMID: 34439863 DOI: 10.3390/biom11081198] [Reference Citation Analysis]
18 Burchard J, Zhang C, Liu AM, Poon RT, Lee NP, Wong KF, Sham PC, Lam BY, Ferguson MD, Tokiwa G, Smith R, Leeson B, Beard R, Lamb JR, Lim L, Mao M, Dai H, Luk JM. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol. 2010;6:402. [PMID: 20739924 DOI: 10.1038/msb.2010.58] [Cited by in Crossref: 126] [Cited by in F6Publishing: 127] [Article Influence: 11.5] [Reference Citation Analysis]
19 Watts JK, Corey DR. Silencing disease genes in the laboratory and the clinic. J Pathol. 2012;226:365-379. [PMID: 22069063 DOI: 10.1002/path.2993] [Cited by in Crossref: 243] [Cited by in F6Publishing: 222] [Article Influence: 22.1] [Reference Citation Analysis]
20 Kurtz CL, Fannin EE, Toth CL, Pearson DS, Vickers KC, Sethupathy P. Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver. Sci Rep 2015;5:12911. [PMID: 26246194 DOI: 10.1038/srep12911] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
21 Chowdhary V, Biswas P, Ghoshal K. Role of Noncoding RNAs in Acetaminophen-Induced Liver Injury. Gene Expr 2021;20:179-88. [PMID: 33757622 DOI: 10.3727/105221621X16165282414118] [Reference Citation Analysis]
22 Chen XM. MicroRNA signatures in liver diseases. World J Gastroenterol 2009; 15(14): 1665-1672 [PMID: 19360909 DOI: 10.3748/wjg.15.1665] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 87] [Article Influence: 6.6] [Reference Citation Analysis]
23 Card PB, Hogg RT, Gil Del Alcazar CR, Gerard RD. MicroRNA silencing improves the tumor specificity of adenoviral transgene expression. Cancer Gene Ther. 2012;19:451-459. [PMID: 22555510 DOI: 10.1038/cgt.2012.16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
24 Kilikevicius A, Meister G, Corey DR. Reexamining assumptions about miRNA-guided gene silencing. Nucleic Acids Res 2021:gkab1256. [PMID: 34967419 DOI: 10.1093/nar/gkab1256] [Reference Citation Analysis]
25 Ogawa A. Isothermal sensitive detection of microRNA using an autonomous DNA machine recycling output as input. Bioorganic & Medicinal Chemistry Letters 2010;20:6056-60. [DOI: 10.1016/j.bmcl.2010.08.055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
26 Mahmoudian-Sani MR, Asgharzade S, Alghasi A, Saeedi-Boroujeni A, Adnani Sadati SJ, Moradi MT. MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma. J Gastrointest Oncol 2019;10:789-96. [PMID: 31392060 DOI: 10.21037/jgo.2019.02.14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
27 Ma J, Li X. MicroRNAs are involved in the toxicity of microcystins. Toxin Reviews 2016;36:165-75. [DOI: 10.1080/15569543.2016.1258713] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
28 Chen SL, Zheng MH, Shi KQ, Yang T, Chen YP. A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job. BioDrugs. 2013;27:25-34. [PMID: 23329398 DOI: 10.1007/s40259-012-0005-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
29 Hou W, Bonkovsky HL. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: Dysregulation and implications for early detection, diagnosis and therapy. World J Gastroenterol 2013; 19(44): 7836-7845 [PMID: 24307777 DOI: 10.3748/wjg.v19.i44.7836] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
30 Sasaki R, Kanda T, Yokosuka O, Kato N, Matsuoka S, Moriyama M. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside. Int J Mol Sci 2019;20:E1406. [PMID: 30897788 DOI: 10.3390/ijms20061406] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
31 Yasukawa K, Liew LC, Hagiwara K, Hironaka-Mitsuhashi A, Qin XY, Furutani Y, Tanaka Y, Nakagama H, Kojima S, Kato T, Ochiya T, Gailhouste L. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion. Cancer Sci 2020;111:869-80. [PMID: 31883160 DOI: 10.1111/cas.14292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
32 Chen XM. MicroRNA signatures in liver diseases. World J Gastroenterol. 2009;15:1665-1672. [PMID: 19360909 DOI: 10.3748/wjg.15.1665;] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 El Tayebi HM, Waly AA, Assal RA, Hosny KA, Esmat G, Abdelaziz AI. Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma. Oncol Lett. 2015;10:3206-3212. [PMID: 26722313 DOI: 10.3892/ol.2015.3725] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
34 Li X, Jiang P, Yu H, Yang Y, Xia L, Yang R, Fang X, Zhao Z. miR-21-3p Targets Elovl5 and Regulates Triglyceride Production in Mammary Epithelial Cells of Cow. DNA and Cell Biology 2019;38:352-7. [DOI: 10.1089/dna.2018.4409] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Roux J, Gonzàlez-Porta M, Robinson-Rechavi M. Comparative analysis of human and mouse expression data illuminates tissue-specific evolutionary patterns of miRNAs. Nucleic Acids Res 2012;40:5890-900. [PMID: 22457063 DOI: 10.1093/nar/gks279] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
36 Li C, Wang Y, Wang S, Wu B, Hao J, Fan H, Ju Y, Ding Y, Chen L, Chu X. Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J Virol. 2013;87:2193-2205. [PMID: 23221562 DOI: 10.1128/jvi.02831-12] [Cited by in Crossref: 94] [Cited by in F6Publishing: 68] [Article Influence: 9.4] [Reference Citation Analysis]
37 Pan F, You J, Liu Y, Qiu X, Yu W, Ma J, Pan L, Zhang A, Zhang Q. Differentially expressed microRNAs in the corpus cavernosum from a murine model with type 2 diabetes mellitus-associated erectile dysfunction. Mol Genet Genomics 2016;291:2215-24. [PMID: 27681254 DOI: 10.1007/s00438-016-1250-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
38 Cheng B, Zhu Q, Lin W, Wang L. MicroRNA-122 inhibits epithelial-mesenchymal transition of hepatic stellate cells induced by the TGF-β1/Smad signaling pathway. Exp Ther Med 2019;17:284-90. [PMID: 30651793 DOI: 10.3892/etm.2018.6962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
39 Zhang D, Lu K, Dong Z, Jiang G, Xu W, Liu W. The effect of exposure to a high-fat diet on microRNA expression in the liver of blunt snout bream (Megalobrama amblycephala). PLoS One 2014;9:e96132. [PMID: 24788396 DOI: 10.1371/journal.pone.0096132] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
40 Cheng D, Chen Y, Lu C, Qian Y, Lv Z. Preliminary profiling of microRNA in the normal and regenerating liver of Chiloscyllium plagiosum. Comp Biochem Physiol Part D Genomics Proteomics 2017;24:60-7. [PMID: 28822868 DOI: 10.1016/j.cbd.2017.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
41 Fu X, Rivera A, Tao L, De Geest B, Zhang X. Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells. Mol Ther. 2012;20:339-346. [PMID: 22146341 DOI: 10.1038/mt.2011.265] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
42 Tarver JE, Taylor RS, Puttick MN, Lloyd GT, Pett W, Fromm B, Schirrmeister BE, Pisani D, Peterson KJ, Donoghue PCJ. Well-Annotated microRNAomes Do Not Evidence Pervasive miRNA Loss. Genome Biol Evol 2018;10:1457-70. [PMID: 29788279 DOI: 10.1093/gbe/evy096] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
43 Shyu YC, Lee TL, Lu MJ, Chen JR, Chien RN, Chen HY, Lin JF, Tsou AP, Chen YH, Hsieh CW, Huang TS. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma. J Transl Med 2016;14:200. [PMID: 27370270 DOI: 10.1186/s12967-016-0956-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
44 Heneghan HM, Miller N, Kerin MJ. Role of microRNAs in obesity and the metabolic syndrome. Obes Rev. 2010;11:354-361. [PMID: 19793375 DOI: 10.1111/j.1467-789x.2009.00659.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 70] [Article Influence: 10.8] [Reference Citation Analysis]
45 Kojima S, Gatfield D, Esau CC, Green CB. MicroRNA-122 modulates the rhythmic expression profile of the circadian deadenylase Nocturnin in mouse liver. PLoS One 2010;5:e11264. [PMID: 20582318 DOI: 10.1371/journal.pone.0011264] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
46 Fu H, Zhang X, Wang Q, Sun Y, Liu L, Huang L, Ding L, Shen M, Zhang L, Duan Y. Simple and rational design of a polymer nano-platform for high performance of HCV related miR-122 reduction in the liver. Biomater Sci 2018;6:2667-80. [PMID: 30209483 DOI: 10.1039/c8bm00639c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
47 McDaniel K, Herrera L, Zhou T, Francis H, Han Y, Levine P, Lin E, Glaser S, Alpini G, Meng F. The functional role of microRNAs in alcoholic liver injury. J Cell Mol Med. 2014;18:197-207. [PMID: 24400890 DOI: 10.1111/jcmm.12223] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 9.6] [Reference Citation Analysis]
48 Fathi-Kazerooni M, Kazemnejad S, Khanjani S, Saltanatpour Z, Tavoosidana G. Down-regulation of miR-122 after transplantation of mesenchymal stem cells in acute liver failure in mice model. Biologicals 2019;58:64-72. [PMID: 30824230 DOI: 10.1016/j.biologicals.2019.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
49 White NM, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM. Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol. 2011;8:75-84. [PMID: 21045789 DOI: 10.1038/nrclinonc.2010.173] [Cited by in Crossref: 136] [Cited by in F6Publishing: 134] [Article Influence: 11.3] [Reference Citation Analysis]
50 Fattahi S, Pilehchian Langroudi M, Akhavan-Niaki H. Hedgehog signaling pathway: Epigenetic regulation and role in disease and cancer development. J Cell Physiol 2018;233:5726-35. [PMID: 29380372 DOI: 10.1002/jcp.26506] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
51 Xu C, Yu C, Li Y. Regulation of Hepatic MicroRNA Expression in Response to Ischemic Preconditioning following Ischemia/Reperfusion Injury in Mice. OMICS: A Journal of Integrative Biology 2009;13:513-20. [DOI: 10.1089/omi.2009.0035] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
52 Hao J, Jin W, Li X, Wang S, Zhang X, Fan H, Li C, Chen L, Gao B, Liu G. Inhibition of alpha interferon (IFN-α)-induced microRNA-122 negatively affects the anti-hepatitis B virus efficiency of IFN-α. J Virol. 2013;87:137-147. [PMID: 23055569 DOI: 10.1128/jvi.01710-12] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
53 Yu X, Zhang S, Wang W. Determination of microRNA-122 in hepatocytes by two-step amplification of duplex-specific nuclease with laser-induced fluorescence detection. Anal Methods 2022. [PMID: 35438691 DOI: 10.1039/d2ay00360k] [Reference Citation Analysis]
54 Selten JW, Verhoeven CJ, Heedfeld V, Roest HP, de Jonge J, Pirenne J, van Pelt J, Ijzermans JNM, Monbaliu D, van der Laan LJW. The release of microRNA-122 during liver preservation is associated with early allograft dysfunction and graft survival after transplantation. Liver Transpl 2017;23:946-56. [PMID: 28388830 DOI: 10.1002/lt.24766] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
55 Lv T, Kong L, Jiang L, Wu H, Wen T, Shi Y, Yang J. Dicer1 facilitates liver regeneration in a manner dependent on the inhibitory effect of miR-21 on Pten and Rhob expression. Life Sci 2019;232:116656. [PMID: 31306658 DOI: 10.1016/j.lfs.2019.116656] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Mirzadeh Azad F, Arabian M, Maleki M, Malakootian M. Small Molecules with Big Impacts on Cardiovascular Diseases. Biochem Genet 2020;58:359-83. [PMID: 31997044 DOI: 10.1007/s10528-020-09948-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
57 Gao D, Zhai A, Qian J, Li A, Li Y, Song W, Zhao H, Yu X, Wu J, Zhang Q, Kao W, Wei L, Zhang F, Zhong Z. Down-regulation of suppressor of cytokine signaling 3 by miR-122 enhances interferon-mediated suppression of hepatitis B virus. Antiviral Res 2015;118:20-8. [PMID: 25766860 DOI: 10.1016/j.antiviral.2015.03.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
58 Bandiera S, Pfeffer S, Baumert TF, Zeisel MB. miR-122--a key factor and therapeutic target in liver disease. J Hepatol. 2015;62:448-457. [PMID: 25308172 DOI: 10.1016/j.jhep.2014.10.004] [Cited by in Crossref: 315] [Cited by in F6Publishing: 313] [Article Influence: 39.4] [Reference Citation Analysis]
59 Wang S, Qiu L, Yan X, Jin W, Wang Y, Chen L, Wu E, Ye X, Gao GF, Wang F, Chen Y, Duan Z, Meng S. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity. Hepatology 2012;55:730-41. [PMID: 22105316 DOI: 10.1002/hep.24809] [Cited by in Crossref: 187] [Cited by in F6Publishing: 179] [Article Influence: 18.7] [Reference Citation Analysis]
60 He J, Zhao K, Zheng L, Xu Z, Gong W, Chen S, Shen X, Huang G, Gao M, Zeng Y, Zhang Y, He F. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells. Mol Cancer 2015;14:163. [PMID: 26302777 DOI: 10.1186/s12943-015-0427-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
61 Zhang G, Wang Q, Xu R. Therapeutics Based on microRNA: A New Approach for Liver Cancer. Curr Genomics 2010;11:311-25. [PMID: 21286309 DOI: 10.2174/138920210791616671] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
62 Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, Li H, Tan W, Wang C, Lin D. Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011;50:136-42. [DOI: 10.1002/mc.20712] [Cited by in Crossref: 379] [Cited by in F6Publishing: 373] [Article Influence: 31.6] [Reference Citation Analysis]
63 Wang WJ, Lai RT, Lu J, Xiang XG, Zhao GD, Tang WL, Cai W, Wang H, Zhou HJ, Xie Q. Correlation between circulating miR-122 and prognosis of chronic HBV-related liver failure. J Dig Dis. 2016;17:334-339. [PMID: 27059663 DOI: 10.1111/1751-2980.12348] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
64 Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev 2015;87:3-14. [PMID: 25979468 DOI: 10.1016/j.addr.2015.05.001] [Cited by in Crossref: 774] [Cited by in F6Publishing: 694] [Article Influence: 110.6] [Reference Citation Analysis]
65 Qiao C, Yuan Z, Li J, He B, Zheng H, Mayer C, Li J, Xiao X. Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver. Gene Ther. 2011;18:403-410. [PMID: 21150938 DOI: 10.1038/gt.2010.157] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 7.3] [Reference Citation Analysis]
66 Lin YC, Chen TH, Huang YM, Wei PL, Lin JC. Involvement of microRNA in Solid Cancer: Role and Regulatory Mechanisms. Biomedicines 2021;9:343. [PMID: 33805515 DOI: 10.3390/biomedicines9040343] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Varnholt H. The role of microRNAs in primary liver cancer. Annals of Hepatology 2008;7:104-13. [DOI: 10.1016/s1665-2681(19)31864-2] [Cited by in Crossref: 40] [Article Influence: 2.9] [Reference Citation Analysis]
68 Kerr TA, Korenblat KM, Davidson NO. MicroRNAs and liver disease. Transl Res. 2011;157:241-252. [PMID: 21420035 DOI: 10.1016/j.trsl.2011.01.008] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
69 Pal AS, Kasinski AL. Animal Models to Study MicroRNA Function. Adv Cancer Res 2017;135:53-118. [PMID: 28882225 DOI: 10.1016/bs.acr.2017.06.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
70 Trattner S, Vestergren AS. Tissue distribution of selected micro RNA in Atlantic salmon. Eur J Lipid Sci Technol 2013;115:1348-56. [DOI: 10.1002/ejlt.201200428] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
71 Zhao X, Ji Z, Xuan R, Wang A, Li Q, Zhao Y, Chao T, Wang J. Characterization of the microRNA Expression Profiles in the Goat Kid Liver. Front Genet 2021;12:794157. [PMID: 35082837 DOI: 10.3389/fgene.2021.794157] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Zhang J, Shi H, Xue M, Yu Q, Yang L, Zheng S, Zhou C. An insertion/deletion polymorphism in the interleukin-1A 3'untranslated region confers risk for gastric cancer. CBM 2016;16:359-65. [DOI: 10.3233/cbm-160574] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Raut A, Khanna A. Enhanced expression of hepatocyte-specific microRNAs in valproic acid mediated hepatic trans-differentiation of human umbilical cord derived mesenchymal stem cells. Exp Cell Res 2016;343:237-47. [PMID: 27001466 DOI: 10.1016/j.yexcr.2016.03.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
74 Li XN, Yang H, Yang T. miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2. Oncol Res 2020;28:41-9. [PMID: 31558184 DOI: 10.3727/096504019X15615433287579] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
75 Ma J, Li Y, Wu M, Zhang C, Che Y, Li W, Li X. Serum immune responses in common carp (Cyprinus carpio L.) to paraquat exposure: The traditional parameters and circulating microRNAs. Fish & Shellfish Immunology 2018;76:133-42. [DOI: 10.1016/j.fsi.2018.02.046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
76 Chai FN, Ma WY, Zhang J, Xu HS, Li YF, Zhou QD, Li XG, Ye XL. Coptisine from Rhizoma coptidis exerts an anti-cancer effect on hepatocellular carcinoma by up-regulating miR-122. Biomed Pharmacother 2018;103:1002-11. [PMID: 29710498 DOI: 10.1016/j.biopha.2018.04.052] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
77 Oksuz Z, Serin MS, Kaplan E, Dogen A, Tezcan S, Aslan G, Emekdas G, Sezgin O, Altintas E, Tiftik EN. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Mol Biol Rep. 2015;42:713-720. [PMID: 25391771 DOI: 10.1007/s11033-014-3819-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
78 Wen Y, Peng S, Fu L, Fu X, Wu D, Liu B, Tan D, Ouyang Y. Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure. Hepatobiliary & Pancreatic Diseases International 2018;17:126-32. [DOI: 10.1016/j.hbpd.2018.03.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
79 Chang Y, Han JA, Kang SM, Jeong SW, Ryu T, Park HS, Yoo JJ, Lee SH, Kim SG, Kim YS, Kim HS, Jin SY, Ryu S, Jang JY. Clinical impact of serum exosomal microRNA in liver fibrosis. PLoS One 2021;16:e0255672. [PMID: 34506494 DOI: 10.1371/journal.pone.0255672] [Reference Citation Analysis]
80 Rivas GA, Rodríguez MC, Rubianes MD, Gutierrez FA, Eguílaz M, Dalmasso PR, Primo EN, Tettamanti C, Ramírez ML, Montemerlo A, Gallay P, Parrado C. Carbon nanotubes-based electrochemical (bio)sensors for biomarkers. Applied Materials Today 2017;9:566-88. [DOI: 10.1016/j.apmt.2017.10.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 9.6] [Reference Citation Analysis]
81 Meng L, Chen Z, Jiang Z, Huang T, Hu J, Luo P, Zhang H, Huang M, Huang L, Chen Y, Lu M, Xu AM, Ying S. MiR-122-5p suppresses the proliferation, migration, and invasion of gastric cancer cells by targeting LYN. Acta Biochim Biophys Sin (Shanghai) 2020;52:49-57. [PMID: 31828293 DOI: 10.1093/abbs/gmz141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
82 Sempere LF, Kauppinen S. Translational Implications of MicroRNAs in Clinical Diagnostics and Therapeutics. Handbook of Cell Signaling. Elsevier; 2010. pp. 2965-81. [DOI: 10.1016/b978-0-12-374145-5.00340-5] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
83 Haldipur B, Bhukya PL, Arankalle V, Lole K. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122. J Virol 2018;92:e01999-17. [PMID: 29540601 DOI: 10.1128/JVI.01999-17] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
84 Habashy DA, El Tayebi HM, Fawzy IO, Hosny KA, Esmat G, Abdelaziz AI. Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma. World J Hepatol 2016; 8(23): 976-984 [PMID: 27621763 DOI: 10.4254/wjh.v8.i23.976] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
85 Nelson PE, Surzycki SJ. Characterization of the oxygenase activity in a mutant of Chlamydomonas reinhardi exhibiting altered ribulosebisphosphate carboxylase. Eur J Biochem 1976;61:475-80. [PMID: 2467 DOI: 10.1111/j.1432-1033.1976.tb10041.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
86 Farid WRR, Pan Q, van der Meer AJP, de Ruiter PE, Ramakrishnaiah V, de Jonge J, Kwekkeboom J, Janssen HLA, Metselaar HJ, Tilanus HW, Kazemier G, van der Laan LJ. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 2012;18:290-7. [DOI: 10.1002/lt.22438] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 13.2] [Reference Citation Analysis]
87 Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 2021;70:784-95. [PMID: 33127832 DOI: 10.1136/gutjnl-2020-322526] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 79.0] [Reference Citation Analysis]
88 Yang F, Li L, Yang R, Wei M, Sheng Y, Ji L. Identification of serum microRNAs as potential toxicological biomarkers for toosendanin-induced liver injury in mice. Phytomedicine 2019;58:152867. [DOI: 10.1016/j.phymed.2019.152867] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
89 Castoldi M, Muckenthaler MU. Regulation of iron homeostasis by microRNAs. Cell Mol Life Sci 2012;69:3945-52. [PMID: 22678662 DOI: 10.1007/s00018-012-1031-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
90 Lendvai G, Kiss A, Kovalszky I, Schaff Z. [Alterations in microRNA expression patterns in liver diseases]. Orv Hetil 2010;151:1843-53. [PMID: 20980222 DOI: 10.1556/OH.2010.28985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
91 Tan X, Lu ZJ, Gao G, Xu Q, Hu L, Fellmann C, Li MZ, Qu H, Lowe SW, Hannon GJ, Elledge SJ. Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy. Proc Natl Acad Sci U S A 2012;109:869-74. [PMID: 22219365 DOI: 10.1073/pnas.1119873109] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
92 Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, Wu Y, Guo B, Shen Y, Landi D. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3’ untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis. 2009;30:2064-2069. [PMID: 19917630 DOI: 10.1093/carcin/bgp283] [Cited by in Crossref: 102] [Cited by in F6Publishing: 106] [Article Influence: 8.5] [Reference Citation Analysis]
93 Lee CG, Kim JG, Kim HJ, Kwon HK, Cho IJ, Choi DW, Lee WH, Kim WD, Hwang SJ, Choi S, Kim SG. Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injury. Kidney Int 2014;86:943-53. [PMID: 24759152 DOI: 10.1038/ki.2014.117] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
94 Ha SY, Yu JI, Choi C, Kang SY, Joh JW, Paik SW, Kim S, Kim M, Park HC, Park CK. Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma. Sci Rep 2019;9:14738. [PMID: 31611609 DOI: 10.1038/s41598-019-50594-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
95 Novellino L, Rossi RL, Bonino F, Cavallone D, Abrignani S, Pagani M, Brunetto MR. Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs. PLoS One. 2012;7:e31952. [PMID: 22470417 DOI: 10.1371/journal.pone.0031952] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
96 Bai S, Nasser MW, Wang B, Hsu SH, Datta J, Kutay H, Yadav A, Nuovo G, Kumar P, Ghoshal K. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem. 2009;284:32015-32027. [PMID: 19726678 DOI: 10.1074/jbc.m109.016774] [Cited by in Crossref: 347] [Cited by in F6Publishing: 224] [Article Influence: 26.7] [Reference Citation Analysis]
97 Mohr R, Özdirik B, Lambrecht J, Demir M, Eschrich J, Geisler L, Hellberg T, Loosen SH, Luedde T, Tacke F, Hammerich L, Roderburg C. From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis. Int J Mol Sci 2021;22:1492. [PMID: 33540837 DOI: 10.3390/ijms22031492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Boutz DR, Collins PJ, Suresh U, Lu M, Ramírez CM, Fernández-Hernando C, Huang Y, Abreu Rde S, Le SY, Shapiro BA. Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J Biol Chem. 2011;286:18066-18078. [PMID: 21402708 DOI: 10.1074/jbc.m110.196451] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
99 Hornby RJ, Starkey Lewis P, Dear J, Goldring C, Park BK. MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans. Expert Rev Clin Pharmacol. 2014;7:349-362. [PMID: 24694030 DOI: 10.1586/17512433.2014.904201] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
100 Fernández-Tussy P, Ruz-Maldonado I, Fernández-Hernando C. MicroRNAs and Circular RNAs in Lipoprotein Metabolism. Curr Atheroscler Rep 2021;23:33. [PMID: 33970351 DOI: 10.1007/s11883-021-00934-3] [Reference Citation Analysis]
101 D’Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010;31:2765-2773. [PMID: 20534597 DOI: 10.1093/eurheartj/ehq167] [Cited by in Crossref: 515] [Cited by in F6Publishing: 504] [Article Influence: 42.9] [Reference Citation Analysis]
102 Zhu L, Yu T, Qi X, Yang B, Shi L, Luo H, He X, Huang K, Xu W. miR-122 plays an important role in ochratoxin A-induced hepatocyte apoptosis in vitro and in vivo. Toxicol Res (Camb) 2016;5:160-7. [PMID: 30090334 DOI: 10.1039/c5tx00104h] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
103 Nakamura M, Kanda T, Sasaki R, Haga Y, Jiang X, Wu S, Nakamoto S, Yokosuka O. MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells. PLoS One. 2015;10:e0144295. [PMID: 26636761 DOI: 10.1371/journal.pone.0144295] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
104 Li X, Ma J, Fang Q, Li Y. Transcription alterations of microRNAs, cytochrome P4501A1 and 3A65, and AhR and PXR in the liver of zebrafish exposed to crude microcystins. Toxicon 2013;73:17-22. [PMID: 23851223 DOI: 10.1016/j.toxicon.2013.07.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
105 Vickers KC, Remaley AT. MicroRNAs in atherosclerosis and lipoprotein metabolism. Curr Opin Endocrinol Diabetes Obes. 2010;17:150-155. [PMID: 20150807 DOI: 10.1097/med.0b013e32833727a1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
106 Yang R, Yang F, Huang Z, Jin Y, Sheng Y, Ji L. Serum microRNA-122-3p, microRNA-194-5p and microRNA-5099 are potential toxicological biomarkers for the hepatotoxicity induced by Airpotato yam. Toxicology Letters 2017;280:125-32. [DOI: 10.1016/j.toxlet.2017.08.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
107 Lin H, Ewing LE, Koturbash I, Gurley BJ, Miousse IR. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects. Food Chem Toxicol 2017;110:229-39. [PMID: 29042291 DOI: 10.1016/j.fct.2017.10.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
108 Roy S, Trautwein C, Luedde T, Roderburg C. A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases. Front Pharmacol 2018;9:805. [PMID: 30158867 DOI: 10.3389/fphar.2018.00805] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
109 Cheng HR, Kao JH, Wu HL, Tseng TC, Liu CH, Yang HC, Su TH, Chen PJ, Chen DS, Liu CJ. Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection. Hepatol Int 2015;9:35-42. [PMID: 25788377 DOI: 10.1007/s12072-014-9591-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
110 Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Tumour Biol. 2016;37:12273-12286. [PMID: 27271989 DOI: 10.1007/s13277-016-5097-8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
111 Liang HW, Wang N, Wang Y, Wang F, Fu Z, Yan X, Zhu H, Diao W, Ding Y, Chen X, Zhang CY, Zen K. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J Hepatol. 2016;64:278-291. [PMID: 26409216 DOI: 10.1016/j.jhep.2015.09.013] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 10.3] [Reference Citation Analysis]
112 Zhang Y, Qian H, Xu J, Gao W. ADAR, the carcinogenesis mechanisms of ADAR and related clinical applications. Ann Transl Med 2019;7:686. [PMID: 31930087 DOI: 10.21037/atm.2019.11.06] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
113 Huang JT, Liu SM, Ma H, Yang Y, Zhang X, Sun H, Zhang X, Xu J, Wang J. Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma. J Cell Physiol. 2016;231:328-335. [PMID: 26291451 DOI: 10.1002/jcp.25135] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
114 Fornari F, Gramantieri L, Callegari E, Shankaraiah RC, Piscaglia F, Negrini M, Giovannini C. MicroRNAs in Animal Models of HCC. Cancers (Basel) 2019;11:E1906. [PMID: 31805631 DOI: 10.3390/cancers11121906] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
115 Aryal B, Rotllan N, Fernández-Hernando C. Noncoding RNAs and atherosclerosis. Curr Atheroscler Rep 2014;16:407. [PMID: 24623179 DOI: 10.1007/s11883-014-0407-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 7.3] [Reference Citation Analysis]
116 Vaulont S. [miR-122, a microRNA gatekeeper of iron homeostasis]. Med Sci (Paris) 2011;27:704-6. [PMID: 21880256 DOI: 10.1051/medsci/2011278010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
117 Naito Y, Tanaka Y, Ochiya T. microRNAs and Hepatitis B. Adv Exp Med Biol 2015;888:389-99. [PMID: 26663193 DOI: 10.1007/978-3-319-22671-2_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
118 Bofill-De Ros X, Villanueva E, Fillat C. Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells. Oncotarget 2015;6:6179-90. [PMID: 25714032 DOI: 10.18632/oncotarget.3350] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
119 Simeonov KP, Uppal H. Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs. PLoS One. 2014;9:e100134. [PMID: 24963715 DOI: 10.1371/journal.pone.0100134] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 6.6] [Reference Citation Analysis]
120 Qiu Z, Dai Y. Roadmap of miR-122-related clinical application from bench to bedside. Expert Opin Investig Drugs 2014;23:347-55. [PMID: 24354366 DOI: 10.1517/13543784.2014.867327] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
121 Hojo H, Yashiro Y, Noda Y, Ogami K, Yamagishi R, Okada S, Hoshino SI, Suzuki T. The RNA-binding protein QKI-7 recruits the poly(A) polymerase GLD-2 for 3' adenylation and selective stabilization of microRNA-122. J Biol Chem 2020;295:390-402. [PMID: 31792053 DOI: 10.1074/jbc.RA119.011617] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
122 Hou W, Tian Q, Zheng J, Bonkovsky HL. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology 2010;51:1494-504. [PMID: 20127796 DOI: 10.1002/hep.23401] [Cited by in Crossref: 141] [Cited by in F6Publishing: 140] [Article Influence: 11.8] [Reference Citation Analysis]
123 Fehr C, Conrad KD, Niepmann M. Differential stimulation of hepatitis C virus RNA translation by microRNA-122 in different cell cycle phases. Cell Cycle 2012;11:277-85. [PMID: 22189820 DOI: 10.4161/cc.11.2.18699] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
124 Chai FN, Zhang J, Xiang HM, Xu HS, Li YF, Ma WY, Li XG, Ye XL. Protective effect of Coptisine from Rhizoma Coptidis on LPS/D-GalN-induced acute liver failure in mice through up-regulating expression of miR-122. Biomed Pharmacother 2018;98:180-90. [PMID: 29253766 DOI: 10.1016/j.biopha.2017.11.133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
125 Liu J, Hu G, Zhou R, Drescher KM, Chen X. MicroRNAs in Epithelial Antimicrobial Immunity. In: Erdmann VA, Barciszewski J, editors. RNA Technologies and Their Applications. Berlin: Springer Berlin Heidelberg; 2010. pp. 355-67. [DOI: 10.1007/978-3-642-12168-5_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
126 Li M, Marin-Muller C, Bharadwaj U, Chow KH, Yao Q, Chen C. MicroRNAs: control and loss of control in human physiology and disease. World J Surg 2009;33:667-84. [PMID: 19030926 DOI: 10.1007/s00268-008-9836-x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 109] [Article Influence: 8.8] [Reference Citation Analysis]
127 Su YW, Chen X, Jiang ZZ, Wang T, Wang C, Zhang Y, Wen J, Xue M, Zhu D, Zhang Y, Su YJ, Xing TY, Zhang CY, Zhang LY. A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in rats. PLoS One 2012;7:e37395. [PMID: 22624025 DOI: 10.1371/journal.pone.0037395] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
128 Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, Wu F. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway. Liver Int 2012;32:752-60. [DOI: 10.1111/j.1478-3231.2011.02750.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 144] [Article Influence: 15.1] [Reference Citation Analysis]
129 Heim MH, Bochud PY, George J. Host - hepatitis C viral interactions: The role of genetics. J Hepatol 2016;65:S22-32. [PMID: 27641986 DOI: 10.1016/j.jhep.2016.07.037] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
130 Sarma NJ, Tiriveedhi V, Crippin JS, Chapman WC, Mohanakumar T. Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis. J Virol. 2014;88:3733-3743. [PMID: 24429361 DOI: 10.1128/jvi.03060-13] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
131 Sharkey JW, Antoine DJ, Park BK. Validation of methods involving miRNA isolation, purification and quantification and the potential of miRNAs to be used as biomarkers of nephrotoxicity. Toxicology 2011;290:136-7. [DOI: 10.1016/j.tox.2011.09.062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
132 Xie Y, Yao J, Jin W, Ren L, Li X. Induction and Maturation of Hepatocyte-Like Cells In Vitro: Focus on Technological Advances and Challenges. Front Cell Dev Biol 2021;9:765980. [PMID: 34901010 DOI: 10.3389/fcell.2021.765980] [Reference Citation Analysis]
133 Li ZY, Xi Y, Zhu WN, Zeng C, Zhang ZQ, Guo ZC, Hao DL, Liu G, Feng L, Chen HZ. Positive regulation of hepatic miR-122 expression by HNF4α. J Hepatol. 2011;55:602-611. [PMID: 21241755 DOI: 10.1016/j.jhep.2010.12.023] [Cited by in Crossref: 94] [Cited by in F6Publishing: 91] [Article Influence: 8.5] [Reference Citation Analysis]
134 Rashidi S, Mansouri R, Ali-Hassanzadeh M, Ghani E, Barazesh A, Karimazar M, Nguewa P, Carrera Silva EA. Highlighting the interplay of microRNAs from Leishmania parasites and infected-host cells. Parasitology 2021;:1-13. [PMID: 34218829 DOI: 10.1017/S0031182021001177] [Reference Citation Analysis]
135 Basu S, Bhattacharyya SN. Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells. Nucleic Acids Res. 2014;42:7170-7185. [PMID: 24813441 DOI: 10.1093/nar/gku346] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 7.5] [Reference Citation Analysis]
136 Wang N, Zhou Y, Jiang L, Li D, Yang J, Zhang CY, Zen K. Urinary microRNA-10a and microRNA-30d serve as novel, sensitive and specific biomarkers for kidney injury. PLoS One. 2012;7:e51140. [PMID: 23272089 DOI: 10.1371/journal.pone.0051140] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
137 Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, Shibuya Y, Hase T. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab. 2011;300:E122-E133. [PMID: 20943752 DOI: 10.1152/ajpendo.00441.2010] [Cited by in Crossref: 147] [Cited by in F6Publishing: 120] [Article Influence: 12.3] [Reference Citation Analysis]
138 Farid WR, Verhoeven CJ, de Jonge J, Metselaar HJ, Kazemier G, van der Laan LJ. The ins and outs of microRNAs as biomarkers in liver disease and transplantation. Transpl Int 2014;27:1222-32. [PMID: 24963540 DOI: 10.1111/tri.12379] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
139 Ramnani P, Gao Y, Ozsoz M, Mulchandani A. Electronic detection of microRNA at attomolar level with high specificity. Anal Chem 2013;85:8061-4. [PMID: 23909395 DOI: 10.1021/ac4018346] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
140 Yu CH, Xu CF, Li YM. Association of MicroRNA-223 expression with hepatic ischemia/reperfusion injury in mice. Dig Dis Sci 2009;54:2362-6. [PMID: 19104939 DOI: 10.1007/s10620-008-0629-8] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
141 Sun J, Zhou Y, Cai H, Lan X, Lei C, Zhao X, Zhang C, Chen H. Discovery of novel and differentially expressed microRNAs between fetal and adult backfat in cattle. PLoS One 2014;9:e90244. [PMID: 24587298 DOI: 10.1371/journal.pone.0090244] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
142 Rasal KD, Iquebal MA, Jaiswal S, Dixit S, Vasam M, Nandi S, Raza M, Sahoo L, Angadi UB, Rai A, Kumar D, Sundaray JK. Liver-Specific microRNA Identification in Farmed Carp, Labeo bata (Hamilton, 1822), Fed with Starch Diet Using High-Throughput Sequencing. Mar Biotechnol (NY) 2019;21:589-95. [PMID: 31346855 DOI: 10.1007/s10126-019-09912-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 De Stefano F, Chacon E, Turcios L, Marti F, Gedaly R. Novel biomarkers in hepatocellular carcinoma. Dig Liver Dis. 2018;50:1115-1123. [PMID: 30217732 DOI: 10.1016/j.dld.2018.08.019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 8.5] [Reference Citation Analysis]
144 Zhang Y, Tan YY, Chen PP, Xu H, Xie SJ, Xu SJ, Li B, Li JH, Liu S, Yang JH, Zhou H, Qu LH. Genome-wide identification of microRNA targets reveals positive regulation of the Hippo pathway by miR-122 during liver development. Cell Death Dis 2021;12:1161. [PMID: 34907157 DOI: 10.1038/s41419-021-04436-7] [Reference Citation Analysis]
145 El Tayebi HM, Hosny KA, Esmat G, Breuhahn K, Abdelaziz AI. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. FEBS Lett. 2012;586:3309-3316. [PMID: 22819824 DOI: 10.1016/j.febslet.2012.06.054] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
146 Brzuzan P, Woźny M, Wolińska L, Piasecka A. Expression profiling in vivo demonstrates rapid changes in liver microRNA levels of whitefish (Coregonus lavaretus) following microcystin-LR exposure. Aquat Toxicol 2012;122-123:188-96. [PMID: 22819808 DOI: 10.1016/j.aquatox.2012.07.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
147 Elfimova N, Sievers E, Eischeid H, Kwiecinski M, Noetel A, Hunt H, Becker D, Frommolt P, Quasdorff M, Steffen HM. Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration. Biochim Biophys Acta. 2013;1833:1190-1198. [PMID: 23391410 DOI: 10.1016/j.bbamcr.2013.01.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
148 Thirion M, Ochiya T. Roles of microRNAs in the hepatitis B virus infection and related diseases. Viruses. 2013;5:2690-2703. [PMID: 24212236 DOI: 10.3390/v5112690] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
149 Kang S, Im K, Baek J, Yoon S, Min H. Macro and small over micro: macromolecules and small molecules that regulate microRNAs. Chembiochem 2014;15:1071-8. [PMID: 24797338 DOI: 10.1002/cbic.201402007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
150 Chen C, Deng B, Qiao M, Zheng R, Chai J, Ding Y, Peng J, Jiang S. Solexa sequencing identification of conserved and novel microRNAs in backfat of Large White and Chinese Meishan pigs. PLoS One 2012;7:e31426. [PMID: 22355364 DOI: 10.1371/journal.pone.0031426] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 6.5] [Reference Citation Analysis]
151 Castoldi M, Vujic Spasic M, Altamura S, Elmén J, Lindow M, Kiss J, Stolte J, Sparla R, D’Alessandro LA, Klingmüller U. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest. 2011;121:1386-1396. [PMID: 21364282 DOI: 10.1172/jci44883] [Cited by in Crossref: 167] [Cited by in F6Publishing: 101] [Article Influence: 15.2] [Reference Citation Analysis]
152 Tryndyak VP, Latendresse JR, Montgomery B, Ross SA, Beland FA, Rusyn I, Pogribny IP. Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet. Toxicol Appl Pharmacol. 2012;262:52-59. [PMID: 22561871 DOI: 10.1016/j.taap.2012.04.018] [Cited by in Crossref: 84] [Cited by in F6Publishing: 77] [Article Influence: 8.4] [Reference Citation Analysis]
153 Ghosh J, Bose M, Roy S, Bhattacharyya SN. Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection. Cell Host Microbe 2013;13:277-88. [PMID: 23498953 DOI: 10.1016/j.chom.2013.02.005] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 10.9] [Reference Citation Analysis]
154 Yi S, Gao ZX, Zhao H, Zeng C, Luo W, Chen B, Wang WM. Identification and characterization of microRNAs involved in growth of blunt snout bream (Megalobrama amblycephala) by Solexa sequencing. BMC Genomics 2013;14:754. [PMID: 24188211 DOI: 10.1186/1471-2164-14-754] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 6.9] [Reference Citation Analysis]
155 Guo H, Xu M, Cao Z, Li W, Chen L, Xie X, Wang W, Liu J. Ultrasound-Assisted miR-122-Loaded Polymeric Nanodroplets for Hepatocellular Carcinoma Gene Therapy. Mol Pharmaceutics 2020. [DOI: 10.1021/acs.molpharmaceut.9b00983] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
156 Pelizzaro F, Cardin R, Sartori A, Imondi A, Penzo B, Aliberti C, Ponzoni A, Vitale A, Cillo U, Farinati F. Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization. Biomedicines 2021;9:890. [PMID: 34440094 DOI: 10.3390/biomedicines9080890] [Reference Citation Analysis]
157 Mennigen JA, Martyniuk CJ, Seiliez I, Panserat S, Skiba-Cassy S. Metabolic consequences of microRNA-122 inhibition in rainbow trout, Oncorhynchus mykiss. BMC Genomics 2014;15:70. [PMID: 24467738 DOI: 10.1186/1471-2164-15-70] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
158 Cheng D, Deng J, Zhang B, He X, Meng Z, Li G, Ye H, Zheng S, Wei L, Deng X, Chen R, Zhou J. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation. EBioMedicine. 2018;36:159-170. [PMID: 30195653 DOI: 10.1016/j.ebiom.2018.08.055] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 13.8] [Reference Citation Analysis]
159 Yin S, Fan Y, Zhang H, Zhao Z, Hao Y, Li J, Sun C, Yang J, Yang Z, Yang X, Lu J, Xi JJ. Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. Nat Commun 2016;7:11012. [PMID: 26987776 DOI: 10.1038/ncomms11012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
160 Fu Z, Wang L, Li S, Chen F, Au-Yeung KK, Shi C. MicroRNA as an Important Target for Anticancer Drug Development. Front Pharmacol 2021;12:736323. [PMID: 34512363 DOI: 10.3389/fphar.2021.736323] [Reference Citation Analysis]
161 Panarelli NC, Yantiss RK. MicroRNA Expression in Selected Carcinomas of the Gastrointestinal Tract. Patholog Res Int 2011;2011:124608. [PMID: 21403819 DOI: 10.4061/2011/124608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
162 Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, French NS, Dhaun N, Webb DJ, Costello EM, Neoptolemos JP, Moggs J, Goldring CE, Park BK. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011;54:1767-76. [PMID: 22045675 DOI: 10.1002/hep.24538] [Cited by in Crossref: 400] [Cited by in F6Publishing: 363] [Article Influence: 36.4] [Reference Citation Analysis]
163 Ghosh S, Börsch A, Ghosh S, Zavolan M. The transcriptional landscape of a hepatoma cell line grown on scaffolds of extracellular matrix proteins. BMC Genomics 2021;22:238. [PMID: 33823809 DOI: 10.1186/s12864-021-07532-2] [Reference Citation Analysis]
164 Lendvai G, Szekerczés T, Kontsek E, Selvam A, Szakos A, Schaff Z, Björnstedt M, Kiss A. The Effect of Methylselenocysteine and Sodium Selenite Treatment on microRNA Expression in Liver Cancer Cell Lines. Pathol Oncol Res 2020;26:2669-81. [PMID: 32656599 DOI: 10.1007/s12253-020-00870-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
165 Huang X, Jie S, Li W, Li H, Ni J, Liu C. miR-122-5p targets GREM2 to protect against glucocorticoid-induced endothelial damage through the BMP signaling pathway. Mol Cell Endocrinol 2021;544:111541. [PMID: 34973370 DOI: 10.1016/j.mce.2021.111541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
166 Rasal KD, Iquebal MA, Pandey A, Behera P, Jaiswal S, Vasam M, Dixit S, Raza M, Sahoo L, Nandi S, Angadi UB, Rai A, Kumar D, Nagpure N, Chaudhari A, Sundaray JK. Revealing liver specific microRNAs linked with carbohydrate metabolism of farmed carp, Labeo rohita (Hamilton, 1822). Genomics 2020;112:32-44. [PMID: 31325488 DOI: 10.1016/j.ygeno.2019.07.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Su J, Wu F, Xia H, Wu Y, Liu S. Accurate cancer cell identification and microRNA silencing induced therapy using tailored DNA tetrahedron nanostructures. Chem Sci 2020;11:80-6. [PMID: 32110359 DOI: 10.1039/c9sc04823e] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
168 Gaedicke S, Zhang X, Schmelzer C, Lou Y, Doering F, Frank J, Rimbach G. Vitamin E dependent microRNA regulation in rat liver. FEBS Lett. 2008;582:3542-3546. [PMID: 18817776 DOI: 10.1016/j.febslet.2008.09.032] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 5.9] [Reference Citation Analysis]
169 Li Q, Wang G, Shan JL, Yang ZX, Wang HZ, Feng J, Zhen JJ, Chen C, Zhang ZM, Xu W. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J Gastroenterol Hepatol. 2010;25:164-171. [PMID: 19793168 DOI: 10.1111/j.1440-1746.2009.05971.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
170 Szabo G, Satishchandran A. MicroRNAs in alcoholic liver disease. Semin Liver Dis. 2015;35:36-42. [PMID: 25632933 DOI: 10.1055/s-0034- 1397347] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
171 Izzotti A, Larghero P, Cartiglia C, Longobardi M, Pfeffer U, Steele VE, De Flora S. Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 2010;31:894-901. [PMID: 20145010 DOI: 10.1093/carcin/bgq037] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
172 Linhares-Lacerda L, Morrot A. Role of Small RNAs in Trypanosomatid Infections. Front Microbiol 2016;7:367. [PMID: 27065454 DOI: 10.3389/fmicb.2016.00367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
173 Amr KS, Elmawgoud Atia HA, Elazeem Elbnhawy RA, Ezzat WM. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma. Genes Dis 2017;4:215-21. [PMID: 30258925 DOI: 10.1016/j.gendis.2017.10.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
174 Miousse IR, Murphy LA, Lin H, Schisler MR, Sun J, Chalbot MG, Sura R, Johnson K, LeBaron MJ, Kavouras IG, Schnackenberg LK, Beger RD, Rasoulpour RJ, Koturbash I. Dose-response analysis of epigenetic, metabolic, and apical endpoints after short-term exposure to experimental hepatotoxicants. Food Chem Toxicol 2017;109:690-702. [PMID: 28495587 DOI: 10.1016/j.fct.2017.05.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
175 Liu W, Yeh S, Chen P. Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2011;1809:678-85. [DOI: 10.1016/j.bbagrm.2011.04.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 5.5] [Reference Citation Analysis]
176 Dai R, Peng F, Xiao X, Gong X, Jiang Y, Zhang M, Tian Y, Xu Y, Ma J, Li M, Luo Y, Gong G. Hepatitis B virus X protein-induced upregulation of CAT-1 stimulates proliferation and inhibits apoptosis in hepatocellular carcinoma cells. Oncotarget 2017;8:60962-74. [PMID: 28977838 DOI: 10.18632/oncotarget.17631] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
177 Chen WS. Advances in the relationship between microRNA and mechanism of human primary hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2009; 17(12): 1218-1223 [DOI: 10.11569/wcjd.v17.i12.1218] [Reference Citation Analysis]
178 Machado MT, Navega S, Dias F, de Sousa MJ, Teixeira AL, Medeiros R. microRNAs for peripheral blood fraction identification: Origin, pathways and forensic relevance. Life Sci 2015;143:98-104. [PMID: 26522049 DOI: 10.1016/j.lfs.2015.10.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
179 Moore KJ, Rayner KJ, Suárez Y, Fernández-Hernando C. The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu Rev Nutr 2011;31:49-63. [PMID: 21548778 DOI: 10.1146/annurev-nutr-081810-160756] [Cited by in Crossref: 101] [Cited by in F6Publishing: 101] [Article Influence: 9.2] [Reference Citation Analysis]
180 Lee HM, Wong WKK, Fan B, Lau ES, Hou Y, O CK, Luk AOY, Chow EYK, Ma RCW, Chan JCN, Kong APS. Detection of increased serum miR-122-5p and miR-455-3p levels before the clinical diagnosis of liver cancer in people with type 2 diabetes. Sci Rep 2021;11:23756. [PMID: 34887498 DOI: 10.1038/s41598-021-03222-x] [Reference Citation Analysis]
181 Nuzzo S, Roscigno G, Affinito A, Ingenito F, Quintavalle C, Condorelli G. Potential and Challenges of Aptamers as Specific Carriers of Therapeutic Oligonucleotides for Precision Medicine in Cancer. Cancers (Basel) 2019;11:E1521. [PMID: 31636244 DOI: 10.3390/cancers11101521] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
182 Shifeng H, Danni W, Pu C, Ping Y, Ju C, Liping Z. Circulating liver-specific miR-122 as a novel potential biomarker for diagnosis of cholestatic liver injury. PLoS One 2013;8:e73133. [PMID: 24086271 DOI: 10.1371/journal.pone.0073133] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
183 Toh TB, Lim JJ, Chow EK. Epigenetics of hepatocellular carcinoma. Clin Transl Med. 2019;8:13. [PMID: 31056726 DOI: 10.1186/s40169-019-0230-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 12.7] [Reference Citation Analysis]
184 Naveed A, ur-Rahman S, Abdullah S, Naveed MA. A Concise Review of MicroRNA Exploring the Insights of MicroRNA Regulations in Bacterial, Viral and Metabolic Diseases. Mol Biotechnol 2017;59:518-29. [DOI: 10.1007/s12033-017-0034-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
185 Yang QJ, Kluger M, Goryński K, Pawliszyn J, Bojko B, Yu A, Noh K, Selzner M, Jerath A, Mccluskey S, Pang KS, Wąsowicz M. Comparing early liver graft function from heart beating and living-donors: A pilot study aiming to identify new biomarkers of liver injury: Liver graft function and novel markers. Biopharm Drug Dispos 2017;38:326-39. [DOI: 10.1002/bdd.2066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
186 Gailhouste L, Liew LC, Yasukawa K, Hatada I, Tanaka Y, Nakagama H, Ochiya T. Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells. Mol Ther 2018;26:1840-54. [PMID: 29759938 DOI: 10.1016/j.ymthe.2018.04.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
187 Kim N, Kim H, Jung I, Kim Y, Kim D, Han YM. Expression profiles of miRNAs in human embryonic stem cells during hepatocyte differentiation. Hepatol Res 2011;41:170-83. [PMID: 21269386 DOI: 10.1111/j.1872-034X.2010.00752.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
188 Bernardi C, Soffientini U, Piacente F, Tonetti MG. Effects of microRNAs on fucosyltransferase 8 (FUT8) expression in hepatocarcinoma cells. PLoS One. 2013;8:e76540. [PMID: 24130780 DOI: 10.1371/journal.pone.0076540] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
189 Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, Fei M, Sun S. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem. 2010;56:1830-1838. [PMID: 20930130 DOI: 10.1373/clinchem.2010.147850] [Cited by in Crossref: 292] [Cited by in F6Publishing: 289] [Article Influence: 24.3] [Reference Citation Analysis]
190 Yuan LT, Lee WJ, Yang YC, Chen BR, Yang CY, Chen MW, Chen JQ, Hsiao M, Chien MH, Hua KT. Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122. Cancers (Basel) 2021;13:2376. [PMID: 34069116 DOI: 10.3390/cancers13102376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
191 Yang F, Zhang L, Wang F, Wang Y, Huo XS, Yin YX, Wang YQ, Zhang L, Sun SH. Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma. Neoplasia 2011;13:590-600. [PMID: 21750653 DOI: 10.1593/neo.11422] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 5.9] [Reference Citation Analysis]
192 Kwon IG, Ha TK, Ryu S, Ha E. Roux-en-Y gastric bypass stimulates hypothalamic miR-122 and inhibits cardiac and hepatic miR-122 expressions. Journal of Surgical Research 2015;199:371-7. [DOI: 10.1016/j.jss.2015.05.055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
193 Liu T, Feng H, Yousuf S, Xie L, Miao X. Genome-Wide Analysis of microRNAs Identifies the Lipid Metabolism Pathway to Be a Defining Factor in Adipose Tissue From Different Sheep. Front Vet Sci 2022;9:938311. [DOI: 10.3389/fvets.2022.938311] [Reference Citation Analysis]
194 Gailhouste L, Gomez-Santos L, Hagiwara K, Hatada I, Kitagawa N, Kawaharada K, Thirion M, Kosaka N, Takahashi RU, Shibata T, Miyajima A, Ochiya T. miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells. Hepatology 2013;58:1153-65. [PMID: 23532995 DOI: 10.1002/hep.26422] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 11.0] [Reference Citation Analysis]
195 Penman AD, Kaufman GE, Daniels KK. MicroRNA expression as an indicator of tissue toxicity. Biomarkers in Toxicology. Elsevier; 2014. pp. 1003-18. [DOI: 10.1016/b978-0-12-404630-6.00060-9] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
196 Lusi EA, Passamano M, Guarascio P, Scarpa A, Schiavo L. Innovative electrochemical approach for an early detection of microRNAs. Anal Chem. 2009;81:2819-2822. [PMID: 19331434 DOI: 10.1021/ac8026788] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 8.2] [Reference Citation Analysis]
197 Rottiers V, Najafi-Shoushtari SH, Kristo F, Gurumurthy S, Zhong L, Li Y, Cohen DE, Gerszten RE, Bardeesy N, Mostoslavsky R, Näär AM. MicroRNAs in metabolism and metabolic diseases. Cold Spring Harb Symp Quant Biol 2011;76:225-33. [PMID: 22156303 DOI: 10.1101/sqb.2011.76.011049] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 7.5] [Reference Citation Analysis]
198 Wu X, Somlo G, Yu Y, Palomares MR, Li AX, Zhou W, Chow A, Yen Y, Rossi JJ, Gao H. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer. J Transl Med. 2012;10:42. [PMID: 22400902 DOI: 10.1186/1479-5876-10-42] [Cited by in Crossref: 149] [Cited by in F6Publishing: 138] [Article Influence: 14.9] [Reference Citation Analysis]
199 Leja J, Nilsson B, Yu D, Gustafson E, Akerström G, Oberg K, Giandomenico V, Essand M. Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability. PLoS One. 2010;5:e8916. [PMID: 20111709 DOI: 10.1371/journal.pone.0008916] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
200 Chen HL, Huang JY, Chen CM, Chu TH, Shih C. MicroRNA-22 can reduce parathymosin expression in transdifferentiated hepatocytes. PLoS One 2012;7:e34116. [PMID: 22493679 DOI: 10.1371/journal.pone.0034116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
201 Wang W, Zhu N, Yan T, Shi YN, Chen J, Zhang CJ, Xie XJ, Liao DF, Qin L. The crosstalk: exosomes and lipid metabolism. Cell Commun Signal 2020;18:119. [PMID: 32746850 DOI: 10.1186/s12964-020-00581-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
202 Yang X, Sun L, Wang L, Yao B, Mo H, Yang W. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4. Biomedicine & Pharmacotherapy 2019;118:109386. [DOI: 10.1016/j.biopha.2019.109386] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
203 Liu WH, Chen CH, Yeh KH, Li CL, Wu YJ, Chen DS, Chen PJ, Yeh SH. ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers. PLoS One 2013;8:e81922. [PMID: 24386085 DOI: 10.1371/journal.pone.0081922] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
204 Boccuto L, Abenavoli L. Genetic and Epigenetic Profile of Patients With Alcoholic Liver Disease. Ann Hepatol. 2017;16:490-500. [PMID: 28612750 DOI: 10.5604/01.3001.0010.0274] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
205 Roderburg C, Benz F, Vargas Cardenas D, Koch A, Janssen J, Vucur M, Gautheron J, Schneider AT, Koppe C, Kreggenwinkel K, Zimmermann HW, Luedde M, Trautwein C, Tacke F, Luedde T. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int. 2015;35:1172-1184. [PMID: 25039534 DOI: 10.1111/liv.12627] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 9.8] [Reference Citation Analysis]
206 Yang G, Zhang M, Zhao Y, Pan Y, Kan M, Li J, He K, Zhang X. HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway. PLoS One 2020;15:e0230450. [PMID: 32210451 DOI: 10.1371/journal.pone.0230450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
207 Chu AS, Friedman JR. A role for microRNA in cystic liver and kidney diseases. J Clin Invest 2008;118:3585-7. [PMID: 18949060 DOI: 10.1172/JCI36870] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
208 Hong L, Han Y, Li S, Yang J, Zheng J, Zhang H, Zhao Q, Wu K, Fan D. The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas. Expert Opin Biol Ther. 2010;10:1693-1701. [PMID: 20977295 DOI: 10.1517/14712598.2010.532482] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
209 Deng LH, Xia Q. MicroRNAs in acute pancreatitis. Shijie Huaren Xiaohua Zazhi 2016; 24(20): 3128-3134 [DOI: 10.11569/wcjd.v24.i20.3128] [Reference Citation Analysis]
210 Wu S, Lin Y, Xu D, Chen J, Shu M, Zhou Y, Zhu W, Su X, Zhou Y, Qiu P, Yan G. MiR-135a functions as a selective killer of malignant glioma. Oncogene 2012;31:3866-74. [PMID: 22139076 DOI: 10.1038/onc.2011.551] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
211 Davoodian N, Lotfi AS, Soleimani M, Mowla SJ. MicroRNA-122 Overexpression Promotes Hepatic Differentiation of Human Adipose Tissue-Derived Stem Cells: mi R-122 R egulates H epatic D ifferentiation of h ADSC s. J Cell Biochem 2014;115:1582-93. [DOI: 10.1002/jcb.24822] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
212 Liu X, Zhu L, Liao S, Xu Z, Zhou Y. The porcine microRNA transcriptome response to transmissible gastroenteritis virus infection. PLoS One 2015;10:e0120377. [PMID: 25781021 DOI: 10.1371/journal.pone.0120377] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
213 Chaker D, Mouawad C, Azar A, Quilliot D, Achkar I, Fajloun Z, Makdissy N. Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte differentiation from human adipose-derived mesenchymal stem cells via the Wnt5a/PI3K/miR-122 pathway: impact of the age of the donor. Stem Cell Res Ther 2018;9. [DOI: 10.1186/s13287-018-0910-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
214 Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, Rusyn I, Beland FA. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest. 2010;90:1437-1446. [PMID: 20548288 DOI: 10.1038/labinvest.2010.113] [Cited by in Crossref: 132] [Cited by in F6Publishing: 132] [Article Influence: 11.0] [Reference Citation Analysis]
215 Liu H, French BA, Li J, Tillman B, French SW. Altered regulation of miR-34a and miR-483-3p in alcoholic hepatitis and DDC fed mice. Exp Mol Pathol 2015;99:552-7. [PMID: 26403328 DOI: 10.1016/j.yexmp.2015.09.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
216 Szabo G, Satishchandran A. MicroRNAs in alcoholic liver disease. Semin Liver Dis 2015;35:36-42. [PMID: 25632933 DOI: 10.1055/s-0034-1397347] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
217 Sharkey JW, Antoine DJ, Park BK. Validation of the isolation and quantification of kidney enriched miRNAs for use as biomarkers. Biomarkers 2012;17:231-9. [PMID: 22356305 DOI: 10.3109/1354750X.2012.657246] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
218 Chen C, Ai H, Ren J, Li W, Li P, Qiao R, Ouyang J, Yang M, Ma J, Huang L. A global view of porcine transcriptome in three tissues from a full-sib pair with extreme phenotypes in growth and fat deposition by paired-end RNA sequencing. BMC Genomics 2011;12:448. [PMID: 21906321 DOI: 10.1186/1471-2164-12-448] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 6.7] [Reference Citation Analysis]
219 Bao CY, Li JF, Zhou YS. Advances in understanding the roles of microRNA in hepatitis virus infection. Shijie Huaren Xiaohua Zazhi 2010; 18(35): 3756-3760 [DOI: 10.11569/wcjd.v18.i35.3756] [Reference Citation Analysis]
220 Li A, Song W, Qian J, Li Y, He J, Zhang Q, Li W, Zhai A, Kao W, Hu Y, Li H, Wu J, Ling H, Zhong Z, Zhang F. MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1. Int J Biochem Cell Biol 2013;45:858-65. [PMID: 23348614 DOI: 10.1016/j.biocel.2013.01.008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
221 Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008;48:2047-63. [PMID: 19003900 DOI: 10.1002/hep.22580] [Cited by in Crossref: 463] [Cited by in F6Publishing: 436] [Article Influence: 33.1] [Reference Citation Analysis]
222 Greene CM, Varley RB, Lawless MW. MicroRNAs and liver cancer associated with iron overload: Therapeutic targets unravelled. World J Gastroenterol 2013; 19(32): 5212-5226 [PMID: 23983424 DOI: 10.3748/wjg.v19.i32.5212] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
223 Li L, Miu KK, Gu S, Cheung HH, Chan WY. Comparison of multi-lineage differentiation of hiPSCs reveals novel miRNAs that regulate lineage specification. Sci Rep 2018;8:9630. [PMID: 29941943 DOI: 10.1038/s41598-018-27719-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
224 Zhang S, Cheng Z, Wang Y, Han T. The Risks of miRNA Therapeutics: In a Drug Target Perspective. Drug Des Devel Ther 2021;15:721-33. [PMID: 33654378 DOI: 10.2147/DDDT.S288859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
225 Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene. 2009;28:3526-3536. [PMID: 19617899 DOI: 10.1038/onc.2009.211] [Cited by in Crossref: 484] [Cited by in F6Publishing: 470] [Article Influence: 37.2] [Reference Citation Analysis]
226 Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, Stokes A, Francis T, Hughart N, Hubble L. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol. 2011;55:1339-1345. [PMID: 21703189 DOI: 10.1016/j.jhep.2011.04.015] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 8.7] [Reference Citation Analysis]
227 Laurent T, Kataoka Y, Kobayashi S, Ando M, Nagamori S, Oda H. Spherical cell shape of FLC-4 cell, a human hepatoma cell, enhances hepatocyte-specific function and suppresses tumor phenotype through the integration of mRNA-microRNA interaction. Biol Open 2012;1:958-64. [PMID: 23213373 DOI: 10.1242/bio.20121438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
228 Mullick Chowdhury S, Wang TY, Bachawal S, Devulapally R, Choe JW, Abou Elkacem L, Yakub BK, Wang DS, Tian L, Paulmurugan R, Willmann JK. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs. J Control Release 2016;238:272-80. [PMID: 27503707 DOI: 10.1016/j.jconrel.2016.08.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
229 Steuerwald NM, Parsons JC, Bennett K, Bates TC, Bonkovsky HL. Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus. Liver Int. 2010;30:1490-1504. [PMID: 20825557 DOI: 10.1111/j.1478-3231.2010.02321.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
230 Zhang HT, Sun J, Yan Y, Cui SH, Wang H, Wang CH, Qiu C, Chen X, Ding JS, Qian HG, Wang JC, Zhang Q. Encapsulated microRNA by gemcitabine prodrug for cancer treatment. J Control Release 2019;316:317-30. [PMID: 31733293 DOI: 10.1016/j.jconrel.2019.11.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
231 Iino I, Kikuchi H, Miyazaki S, Hiramatsu Y, Ohta M, Kamiya K, Kusama Y, Baba S, Setou M, Konno H. Effect of miR-122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis. Cancer Sci 2013;104:624-30. [PMID: 23373973 DOI: 10.1111/cas.12122] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
232 Yuan X, Zhang Q, Li Z, Zhang X, Bao S, Fan D, Ru Y, Dong S, Zhang Y, Zhang Y, Ye Z, Xiong D. Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically. Cancer Lett 2016;381:85-95. [PMID: 27450327 DOI: 10.1016/j.canlet.2016.07.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
233 Wang S, Luan J, Lv X. Inhibition of Endoplasmic Reticulum Stress Attenuated Ethanol-Induced Exosomal miR-122 and Acute Liver Injury in Mice. Alcohol Alcohol 2019;54:465-71. [PMID: 31361816 DOI: 10.1093/alcalc/agz058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
234 Sanjay S, Girish C. Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury. Eur J Clin Pharmacol 2017;73:399-407. [PMID: 28028586 DOI: 10.1007/s00228-016-2183-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
235 Chen QQ, Zhang C, Qin MQ, Li J, Wang H, Xu DX, Wang JQ. Inositol-Requiring Enzyme 1 Alpha Endoribonuclease Specific Inhibitor STF-083010 Alleviates Carbon Tetrachloride Induced Liver Injury and Liver Fibrosis in Mice. Front Pharmacol 2018;9:1344. [PMID: 30538632 DOI: 10.3389/fphar.2018.01344] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
236 Palkina NV, Komina AV, Aksenenko MB, Belonogov RN, Lavrentev SN, Ruksha TG. Toxicity of miR-204-5p Inhibition for Melanoma B16 Cells in vitro and Mice in vivo. Cell Tiss Biol 2018;12:307-14. [DOI: 10.1134/s1990519x18040077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
237 Li HD, Du XS, Huang HM, Chen X, Yang Y, Huang C, Meng XM, Li J. Noncoding RNAs in alcoholic liver disease. J Cell Physiol 2019. [PMID: 30701547 DOI: 10.1002/jcp.28229] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
238 Jung CJ, Iyengar S, Blahnik KR, Ajuha TP, Jiang JX, Farnham PJ, Zern M. Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation. PLoS One. 2011;6:e27740. [PMID: 22140464 DOI: 10.1371/journal.pone.0027740] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
239 Ladeiro Y, Zucman-rossi J. Micro-ARN (miARN) et cancer : le cas des tumeurs hépatocellulaires. Med Sci (Paris) 2009;25:467-72. [DOI: 10.1051/medsci/2009255467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
240 Hoy AM, Lundie RJ, Ivens A, Quintana JF, Nausch N, Forster T, Jones F, Kabatereine NB, Dunne DW, Mutapi F, Macdonald AS, Buck AH. Parasite-derived microRNAs in host serum as novel biomarkers of helminth infection. PLoS Negl Trop Dis 2014;8:e2701. [PMID: 24587461 DOI: 10.1371/journal.pntd.0002701] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 12.5] [Reference Citation Analysis]
241 Vares G, Wang B, Ishii-Ohba H, Nenoi M, Nakajima T. Diet-induced obesity modulates epigenetic responses to ionizing radiation in mice. PLoS One 2014;9:e106277. [PMID: 25171162 DOI: 10.1371/journal.pone.0106277] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
242 Xu G, Zhang Y, Jia H, Li J, Liu X, Engelhardt JF, Wang Y. Cloning and identification of microRNAs in bovine alveolar macrophages. Mol Cell Biochem 2009;332:9-16. [DOI: 10.1007/s11010-009-0168-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
243 Kim KH, Lee JI, Kim OH, Hong HE, Kwak BJ, Choi HJ, Ahn J, Lee TY, Lee SC, Kim SJ. Ameliorating liver fibrosis in an animal model using the secretome released from miR-122-transfected adipose-derived stem cells. World J Stem Cells 2019; 11(11): 990-1004 [PMID: 31768225 DOI: 10.4252/wjsc.v11.i11.990] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
244 Czaja AJ. Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis. Aliment Pharmacol Ther 2017;46:920-37. [DOI: 10.1111/apt.14324] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
245 Brzuzan P, Florczyk M, Łakomiak A, Woźny M. Illumina Sequencing Reveals Aberrant Expression of MicroRNAs and Their Variants in Whitefish (Coregonus lavaretus) Liver after Exposure to Microcystin-LR. PLoS One 2016;11:e0158899. [PMID: 27391076 DOI: 10.1371/journal.pone.0158899] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
246 Reddy AM, Zheng Y, Jagadeeswaran G, Macmil SL, Graham WB, Roe BA, Desilva U, Zhang W, Sunkar R. Cloning, characterization and expression analysis of porcine microRNAs. BMC Genomics. 2009;10:65. [PMID: 19196471 DOI: 10.1186/1471-2164-10-65] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 5.8] [Reference Citation Analysis]
247 Jiang M, Ma W, Gao Y, Jia K, Zhang Y, Liu H, Sun Q. IL-22-induced miR-122-5p promotes keratinocyte proliferation by targeting Sprouty2. Exp Dermatol 2017;26:368-74. [PMID: 27943426 DOI: 10.1111/exd.13270] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
248 Shah N, Nelson JE, Kowdley KV. MicroRNAs in Liver Disease: Bench to Bedside. J Clin Exp Hepatol. 2013;3:231-242. [PMID: 25755505 DOI: 10.1016/j.jceh.2013.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
249 Schwarzenbach H, Gahan PB. MicroRNA Shuttle from Cell-To-Cell by Exosomes and Its Impact in Cancer. Noncoding RNA 2019;5:E28. [PMID: 30901915 DOI: 10.3390/ncrna5010028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
250 De Minicis S, Marzioni M, Benedetti A, Svegliati-Baroni G. New insights in hepatocellular carcinoma: from bench to bedside. Ann Transl Med 2013;1:15. [PMID: 25332959 DOI: 10.3978/j.issn.2305-5839.2013.01.06] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
251 Peterson MF, Otoc N, Sethi JK, Gupta A, Antes TJ. Integrated systems for exosome investigation. Methods 2015;87:31-45. [PMID: 25916618 DOI: 10.1016/j.ymeth.2015.04.015] [Cited by in Crossref: 104] [Cited by in F6Publishing: 110] [Article Influence: 14.9] [Reference Citation Analysis]
252 Whitmill A, Kim S, Rojas V, Gulraiz F, Afreen K, Jain M, Singh M, Park IW. Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection. PLoS One 2018;13:e0202524. [PMID: 30138348 DOI: 10.1371/journal.pone.0202524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
253 Stilling G, Sun Z, Zhang S, Jin L, Righi A, Kovācs G, Korbonits M, Scheithauer BW, Kovacs K, Lloyd RV. MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas. Endocr 2010;38:67-75. [DOI: 10.1007/s12020-010-9346-0] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
254 Sonkoly E, Pivarcsi A. Advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med. 2009;13:24-38. [PMID: 19175698 DOI: 10.1111/j.1582-4934.2008.00534.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 112] [Article Influence: 8.7] [Reference Citation Analysis]
255 Singh SK, Pal Bhadra M, Girschick HJ, Bhadra U. MicroRNAs--micro in size but macro in function. FEBS J 2008;275:4929-44. [PMID: 18754771 DOI: 10.1111/j.1742-4658.2008.06624.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 7.1] [Reference Citation Analysis]
256 Suehiro T, Miyaaki H, Kanda Y, Shibata H, Honda T, Ozawa E, Miuma S, Taura N, Nakao K. Serum exosomal microRNA-122 and microRNA-21 as predictive biomarkers in transarterial chemoembolization-treated hepatocellular carcinoma patients. Oncol Lett. 2018;16:3267-3273. [PMID: 30127924 DOI: 10.3892/ol.2018.8991] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
257 Tipanee J, Di Matteo M, Tulalamba W, Samara-Kuko E, Keirsse J, Van Ginderachter JA, Chuah MK, VandenDriessche T. Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons. Mol Ther Nucleic Acids 2020;19:1309-29. [PMID: 32160703 DOI: 10.1016/j.omtn.2020.01.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
258 Migita K, Komori A, Kozuru H, Jiuchi Y, Nakamura M, Yasunami M, Furukawa H, Abiru S, Yamasaki K, Nagaoka S, Hashimoto S, Bekki S, Kamitsukasa H, Nakamura Y, Ohta H, Shimada M, Takahashi H, Mita E, Hijioka T, Yamashita H, Kouno H, Nakamuta M, Ario K, Muro T, Sakai H, Sugi K, Nishimura H, Yoshizawa K, Sato T, Naganuma A, Komatsu T, Oohara Y, Makita F, Tomizawa M, Yatsuhashi H. Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis. PLoS One. 2015;10:e0136908. [PMID: 26575387 DOI: 10.1371/journal.pone.0136908] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
259 Oliveira KG, Malta FM, Nastri AC, Widman A, Faria PL, Santana RA, Alves VA, Carrilho FJ, Pinho JR. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3. Med Microbiol Immunol 2016;205:111-7. [PMID: 26272127 DOI: 10.1007/s00430-015-0431-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
260 Elamin BK, Callegari E, Gramantieri L, Sabbioni S, Negrini M. MicroRNA response to environmental mutagens in liver. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2011;717:67-76. [DOI: 10.1016/j.mrfmmm.2011.03.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
261 Zhang C, Huys A, Thibault PA, Wilson JA. Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance. Virology 2012;433:479-88. [PMID: 22999255 DOI: 10.1016/j.virol.2012.08.039] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
262 Rong X, Sun-waterhouse D, Wang D, Jiang Y, Li F, Chen Y, Zhao S, Li D. The Significance of Regulatory MicroRNAs: Their Roles in Toxicodynamics of Mycotoxins and in the Protection Offered by Dietary Therapeutics Against Mycotoxin-Induced Toxicity: MiRNAs and toxicity of mycotoxins…. Comprehensive Reviews in Food Science and Food Safety 2019;18:48-66. [DOI: 10.1111/1541-4337.12412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
263 Lakner AM, Bonkovsky HL, Schrum LW. microRNAs: Fad or future of liver disease. World J Gastroenterol 2011; 17(20): 2536-2542 [PMID: 21633658 DOI: 10.3748/wjg.v17.i20.2536] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
264 Wang SC, Lin XL, Li J, Zhang TT, Wang HY, Shi JW, Yang S, Zhao WT, Xie RY, Wei F. MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. PLoS One. 2014;9:e101330. [PMID: 24992599 DOI: 10.1371/journal.pone.0101330] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]